Detalhe da pesquisa
1.
Establishment of canine mammary gland tumor cell lines harboring PI3K/Akt activation as a therapeutic target.
BMC Vet Res
; 20(1): 233, 2024 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38807154
2.
Mutational evolution after chemotherapy-progression in metastatic colorectal cancer revealed by circulating tumor DNA analysis.
Int J Cancer
; 153(3): 571-583, 2023 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37194418
3.
Personalised circulating tumour DNA assay with large-scale mutation coverage for sensitive minimal residual disease detection in colorectal cancer.
Br J Cancer
; 129(2): 374-381, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37280413
4.
Dynamic changes in longitudinal circulating tumour DNA profile during metastatic colorectal cancer treatment.
Br J Cancer
; 127(5): 898-907, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35643791
5.
Phenotype-based single cell sequencing identifies diverse genetic subclones in CD133 positive cancer stem cells.
Biochem Biophys Res Commun
; 558: 209-215, 2021 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32958251
6.
Activation of WNT/ß-catenin signaling results in resistance to a dual PI3K/mTOR inhibitor in colorectal cancer cells harboring PIK3CA mutations.
Int J Cancer
; 144(2): 389-401, 2019 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29978469
7.
Association of pathway mutation with survival after recurrence in colorectal cancer patients treated with adjuvant fluoropyrimidine and oxaliplatin chemotherapy.
BMC Cancer
; 19(1): 421, 2019 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31060539
8.
Association Between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer.
Ann Surg Oncol
; 25(11): 3389-3395, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30062471
9.
Dynamic cohesin-mediated chromatin architecture controls epithelial-mesenchymal plasticity in cancer.
EMBO Rep
; 17(9): 1343-59, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27466323
10.
Reduced cohesin destabilizes high-level gene amplification by disrupting pre-replication complex bindings in human cancers with chromosomal instability.
Nucleic Acids Res
; 44(2): 558-72, 2016 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-26420833
11.
Association between mutations of critical pathway genes and survival outcomes according to the tumor location in colorectal cancer.
Cancer
; 123(18): 3513-3523, 2017 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28513830
12.
Identification of long-range epigenetic silencing on chromosome 15q25 and its clinical implication in gastric cancer.
Am J Pathol
; 185(3): 666-78, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25576785
13.
Predicting disease recurrence in limited disease small cell lung cancer using cell-free DNA-based mutation and fragmentome analyses.
Transl Lung Cancer Res
; 13(2): 280-291, 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38496698
14.
Analytical and Clinical Validation of a Highly Sensitive NGS-Based ctDNA Assay with Real-World Concordance in NSCLC.
Cancer Res Treat
; 2024 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38186238
15.
Proteomic analysis reveals that CD147/EMMPRIN confers chemoresistance in cancer stem cell-like cells.
Proteomics
; 13(10-11): 1714-25, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23554123
16.
Gefitinib resistance of cancer cells correlated with TM4SF5-mediated epithelial-mesenchymal transition.
Biochim Biophys Acta
; 1823(2): 514-23, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22178131
17.
EBS-seq: enrichment-based method for accurate analysis of 5-hydroxymethylcytosine at single-base resolution.
Clin Epigenetics
; 15(1): 34, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36859282
18.
Accurate Detection of Urothelial Bladder Cancer Using Targeted Deep Sequencing of Urine DNA.
Cancers (Basel)
; 15(10)2023 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37345205
19.
Practical Utility of Liquid Biopsies for Evaluating Genomic Alterations in Castration-Resistant Prostate Cancer.
Cancers (Basel)
; 15(10)2023 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37345184
20.
Circulating Tumor DNA Dynamics and Treatment Outcome of Regorafenib in Metastatic Colorectal Cancer.
Cancer Res Treat
; 55(3): 927-938, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36915247